IRME logo

IR-Med Inc. Stock Price

OTCPK:IRME Community·US$2.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

IRME Share Price Performance

US$0.034
-0.47 (-93.22%)
US$0.034
-0.47 (-93.22%)
Price US$0.034

IRME Community Narratives

There are no narratives available yet.

Snowflake Analysis

Moderate risk with imperfect balance sheet.

5 Risks
0 Rewards

IR-Med Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$2.4m

Other Expenses

-US$2.3m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.03
0%
0%
-33.3%
View Full Analysis

About IRME

Founded
n/a
Employees
4
CEO
Ran Ziskind
WebsiteView website
www.ir-medical.com

IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications. The company’s development products pipeline consists of PressureSafe, a handheld skin-agnostic optical monitoring device that supports early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; DiaSafe, a handheld optical monitoring device, which supports early detection of diabetic foot ulcers in lower limb skin and underlying tissue caused by prolonged pressure on the sole of diabetic patients; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear, a common malady in children. IR-Med Inc. is headquartered in Rosh Pinna, Israel.

Recent IRME News & Updates

Recent updates

No updates